452 related articles for article (PubMed ID: 32376597)
21. Weathering the Cytokine Storm in COVID-19: Therapeutic Implications.
Iannaccone G; Scacciavillani R; Del Buono MG; Camilli M; Ronco C; Lavie CJ; Abbate A; Crea F; Massetti M; Aspromonte N
Cardiorenal Med; 2020; 10(5):277-287. PubMed ID: 32599589
[TBL] [Abstract][Full Text] [Related]
22. Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians.
Attanasi M; Pasini S; Caronni A; Pellegrino GM; Faverio P; Di Pillo S; Cimino MM; Cipolla G; Chiarelli F; Centanni S; Sferrazza Papa GF;
Respiration; 2020; 99(8):667-677. PubMed ID: 32756065
[TBL] [Abstract][Full Text] [Related]
23. Cytokine storm and use of anakinra in a patient with COVID-19.
Nemchand P; Tahir H; Mediwake R; Lee J
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32933914
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment.
González-García A; García-Sánchez I; Lopes V; Moreno-Arrones OM; Tortosa-Cabañas M; Elías-Sáenz I; Hernández-Rodríguez J
Rheumatology (Oxford); 2020 Aug; 59(8):2171-2173. PubMed ID: 32568376
[No Abstract] [Full Text] [Related]
25. Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome.
Steinhardt MJ; Wiebecke S; Weismann D; Frantz S; Tony HP; Klinker H; Schmalzing M
Scand J Rheumatol; 2020 Sep; 49(5):414-416. PubMed ID: 32914670
[No Abstract] [Full Text] [Related]
26. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
Martinez Navarro W; Ly L; Segal MS; Shukla AM
Asia Pac J Ophthalmol (Phila); 2020; 9(4):374-375. PubMed ID: 32740071
[No Abstract] [Full Text] [Related]
27. Imatinib for COVID-19: A case report.
Morales-Ortega A; Bernal-Bello D; Llarena-Barroso C; Frutos-Pérez B; Duarte-Millán MÁ; García de Viedma-García V; Farfán-Sedano AI; Canalejo-Castrillero E; Ruiz-Giardín JM; Ruiz-Ruiz J; San Martín-López JV
Clin Immunol; 2020 Sep; 218():108518. PubMed ID: 32599278
[No Abstract] [Full Text] [Related]
28. A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial.
Hinks TSC; Barber VS; Black J; Dutton SJ; Jabeen M; Melhorn J; Rahman NM; Richards D; Lasserson D; Pavord ID; Bafadhel M
Trials; 2020 Aug; 21(1):718. PubMed ID: 32807209
[TBL] [Abstract][Full Text] [Related]
29. Neuroleptic malignant syndrome in a COVID-19 patient.
Kajani R; Apramian A; Vega A; Ubhayakar N; Xu P; Liu A
Brain Behav Immun; 2020 Aug; 88():28-29. PubMed ID: 32425332
[No Abstract] [Full Text] [Related]
30. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.
Liu XH; Lu SH; Chen J; Xia L; Yang ZG; Charles S; Yang Y; Lin Y; Lu HZ
Emerg Microbes Infect; 2020 Dec; 9(1):1230-1232. PubMed ID: 32515651
[No Abstract] [Full Text] [Related]
31. Changes of CT findings in a 2019 novel coronavirus (2019-nCoV) pneumonia patient.
Fang X; Zhao M; Li S; Yang L; Wu B
QJM; 2020 Apr; 113(4):271-272. PubMed ID: 32073631
[No Abstract] [Full Text] [Related]
32. The baby lung and the COVID-19 era.
Gattinoni L; Meissner K; Marini JJ
Intensive Care Med; 2020 Jul; 46(7):1438-1440. PubMed ID: 32451579
[No Abstract] [Full Text] [Related]
33. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
[TBL] [Abstract][Full Text] [Related]
34. Clinical improvement of severe COVID-19 pneumonia in a pregnant patient after caesarean delivery.
Oliva M; Hsu K; Alsamarai S; Chavez V; Ferrara L
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32675129
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report.
Franzetti M; Pozzetti U; Carugati M; Pandolfo A; Molteni C; Faccioli P; Castaldo G; Longoni E; Ormas V; Iemoli E; Piconi S
Int J Infect Dis; 2020 Aug; 97():215-218. PubMed ID: 32422376
[TBL] [Abstract][Full Text] [Related]
36. "No dose" lung ultrasound correlation with "low dose" CT scan for early diagnosis of SARS-CoV-2 pneumonia.
Duclos G; Lopez A; Leone M; Zieleskiewicz L
Intensive Care Med; 2020 Jun; 46(6):1103-1104. PubMed ID: 32367166
[No Abstract] [Full Text] [Related]
37. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
38. Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.
D'Andrea S; Berardicurti O; Berardicurti A; Felzani G; Francavilla F; Francavilla S; Giacomelli R; Barbonetti A
Spinal Cord Ser Cases; 2020 Aug; 6(1):69. PubMed ID: 32753638
[TBL] [Abstract][Full Text] [Related]
39. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in".
Castelli V; Cimini A; Ferri C
Front Immunol; 2020; 11():2132. PubMed ID: 32983172
[TBL] [Abstract][Full Text] [Related]
40. An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication.
Weehuizen JM; Hoepelman AIM
Eur J Clin Invest; 2020 Jul; 50(7):e13297. PubMed ID: 32474918
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
